American Vanguard Corporation (NYSE:AVD – Get Free Report) Director Patrick Gottschalk bought 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was bought at an average cost of $2.92 per share, for a total transaction of $58,400.00. Following the completion of the transaction, the director directly owned 146,705 shares of the company’s stock, valued at approximately $428,378.60. The trade was a 15.78% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
American Vanguard Price Performance
AVD opened at $2.87 on Friday. The company’s 50 day simple moving average is $2.79 and its 200 day simple moving average is $3.93. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.41 and a current ratio of 2.32. American Vanguard Corporation has a 1 year low of $2.05 and a 1 year high of $5.92. The stock has a market capitalization of $81.97 million, a PE ratio of -1.80 and a beta of 1.48.
American Vanguard (NYSE:AVD – Get Free Report) last released its earnings results on Wednesday, May 6th. The basic materials company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.08). American Vanguard had a negative return on equity of 4.13% and a negative net margin of 8.71%.The company had revenue of $123.57 million during the quarter, compared to analyst estimates of $120.00 million.
Institutional Inflows and Outflows
Analysts Set New Price Targets
Separately, Weiss Ratings cut shares of American Vanguard from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, American Vanguard currently has a consensus rating of “Hold” and an average target price of $12.00.
Get Our Latest Stock Analysis on American Vanguard
About American Vanguard
American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.
The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.
Featured Articles
- Five stocks we like better than American Vanguard
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.
